{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:36:11Z","timestamp":1785929771279,"version":"3.56.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00079"],"award-info":[{"award-number":["PI15\/00079"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grifols","award":["GATRA"],"award-info":[{"award-number":["GATRA"]}]},{"name":"Fundaci\u00f3n Seneca","award":["19873\/GERM\/15"],"award-info":[{"award-number":["19873\/GERM\/15"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.thromres.2018.07.008","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T18:03:06Z","timestamp":1530813786000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"special_numbering":"C","title":["The genetics of antithrombin"],"prefix":"10.1016","volume":"169","author":[{"given":"Javier","family":"Corral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eugenia","family":"de la Morena-Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2018.07.008_bb0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-0038-1651113","article-title":"Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis","volume":"57","author":"Toulon","year":"1987","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0010","first-page":"17","article-title":"Antithrombin. A bloody important serpin","volume":"425","author":"Bjork","year":"1997","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.thromres.2018.07.008_bb0015","first-page":"238","article-title":"Thrombosis as a conformational disease","volume":"90","author":"Corral","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2018.07.008_bb0020","doi-asserted-by":"crossref","first-page":"12528","DOI":"10.1016\/S0021-9258(18)42309-5","article-title":"Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement","volume":"267","author":"Olson","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2018.07.008_bb0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0950-3536(89)80054-X","article-title":"Antithrombin: structure, genomic organization, function and inherited deficiency","volume":"2","author":"Lane","year":"1989","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.thromres.2018.07.008_bb0030","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1160\/TH15-08-0687","article-title":"Antithrombin: anti-inflammatory properties and clinical applications","volume":"115","author":"Levy","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0035","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1126\/science.285.5435.1926","article-title":"Antiangiogenic activity of the cleaved conformation of the serpin antithrombin","volume":"285","author":"O'Reilly","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.thromres.2018.07.008_bb0040","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jhep.2012.06.023","article-title":"Protective role of antithrombin in mouse models of liver injury","volume":"57","author":"Guerrero","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2018.07.008_bb0045","article-title":"Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase","volume":"8","author":"Luengo-Gil","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2018.07.008_bb0050","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1538-7836.2012.04858.x","article-title":"Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism","volume":"10","author":"Bucciarelli","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0055","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1055\/s-0038-1656297","article-title":"Inherited antithrombin deficiency causing thrombophilia","volume":"13","author":"Egeberg","year":"1965","journal-title":"Thromb. Diath. Haemorrh."},{"key":"10.1016\/j.thromres.2018.07.008_bb0060","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1172\/JCI10489","article-title":"Complete antithrombin deficiency in mice results in embryonic lethality","volume":"106","author":"Ishiguro","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2018.07.008_bb0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2141.1990.tb02635.x","article-title":"Antithrombin III activity in healthy blood donors: age and sex related changes and prevalence of asymptomatic deficiency","volume":"75","author":"Tait","year":"1990","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2018.07.008_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrcardio.2013.211","article-title":"Inherited risk factors for venous thromboembolism","volume":"11","author":"Martinelli","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.thromres.2018.07.008_bb0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11239-015-1316-1","article-title":"Guidance for the evaluation and treatment of hereditary and acquired thrombophilia","volume":"41","author":"Stevens","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2018.07.008_bb0080","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1182\/blood-2008-10-184879","article-title":"Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives","volume":"113","author":"Lijfering","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.07.008_bb0085","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/1060028016651276","article-title":"Issues in the diagnosis and management of hereditary antithrombin deficiency","volume":"50","author":"Bauer","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.thromres.2018.07.008_bb0090","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1538-7836.2010.03840.x","article-title":"A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin","volume":"8","author":"Mahmoodi","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0095","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.thromres.2015.04.012","article-title":"Puzzling questions on antithrombin: diagnostic limitations and real incidence in venous and arterial thrombosis","volume":"135","author":"Corral","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2018.07.008_bb0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1160\/TH11-12-0875","article-title":"Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort","volume":"108","author":"Caspers","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1160\/TH10-08-0538","article-title":"Molecular basis of antithrombin deficiency","volume":"105","author":"Luxembourg","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0110","article-title":"Identification of regulatory mutations in SERPINC1 affecting vitamin D response elements associated with antithrombin deficiency","volume":"11","author":"Toderici","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2018.07.008_bb0115","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1160\/TH11-10-0701","article-title":"Regulatory regions of SERPINC1 gene: identification of the first mutation associated with antithrombin deficiency","volume":"107","author":"de la Morena-Barrio","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0120","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1538-7836.2012.04839.x","article-title":"Type II antithrombin deficiency caused by a large in-frame insertion. Structural, functional and pathological relevance","volume":"10","author":"Martinez-Martinez","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0125","doi-asserted-by":"crossref","first-page":"16513","DOI":"10.1074\/jbc.M117.787325","article-title":"Disease-causing mutations in the serpin antithrombin reveal a key domain critical for inhibiting protease activities","volume":"292","author":"Aguila","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2018.07.008_bb0130","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1160\/TH16-11-0866","article-title":"High levels of latent antithrombin in plasma from patients with antithrombin deficiency","volume":"117","author":"de la Morena-Barrio","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0135","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1042\/BCJ20160014","article-title":"Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance","volume":"473","author":"Gettins","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.thromres.2018.07.008_bb0140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1751-553X.2011.01307.x","article-title":"The phenotypic and genetic assessment of antithrombin deficiency","volume":"33","author":"Cooper","year":"2011","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2018.07.008_bb0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.thromres.2013.05.012","article-title":"Great discrepancy in antithrombin activity measured using five commercially available functional assays","volume":"132","author":"Javela","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2018.07.008_bb0150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2005-863807","article-title":"Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program","volume":"31","author":"Jennings","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0155","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1538-7836.2007.02395.x","article-title":"Detecting antithrombin deficiency may be a difficult task\u2014more than one test is necessary","volume":"5","author":"Kristensen","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.thromres.2014.10.023","article-title":"Development of a novel, rapid assay for detection of heparin-binding defect antithrombin deficiencies: the heparin-antithrombin binding (HAB) ratio","volume":"135","author":"Moore","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2018.07.008_bb0165","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.thromres.2015.03.013","article-title":"Antithrombin heparin binding site deficiency: a challenging diagnosis of a not so benign thrombophilia","volume":"135","author":"Orlando","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2018.07.008_bb0170","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood-2001-11-0047","article-title":"Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?","volume":"99","author":"Ungerstedt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.07.008_bb0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-0037-1614973","article-title":"Antithrombin Cambridge II (Ala384Ser): clinical, functional and haplotype analysis of 18 families","volume":"79","author":"Perry","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0180","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1182\/blood-2006-08-040774","article-title":"Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis","volume":"109","author":"Corral","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.07.008_bb0185","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1182\/blood-2003-05-1560","article-title":"Heparin-induced substrate behavior of antithrombin Cambridge II","volume":"102","author":"Mushunje","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.07.008_bb0190","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/bies.1094","article-title":"Hot news: temperature-sensitive humans explain hereditary disease","volume":"23","author":"Friedberg","year":"2001","journal-title":"BioEssays"},{"key":"10.1016\/j.thromres.2018.07.008_bb0195","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1182\/blood.V92.8.2696","article-title":"Antithrombins Wibble and Wobble (T85M\/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation","volume":"92","author":"Beauchamp","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.07.008_bb0200","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1172\/JCI117589","article-title":"Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn\u2192Asp)","volume":"94","author":"Bruce","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2018.07.008_bb0205","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1160\/TH15-11-0871","article-title":"Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate risk of thrombosis that causes a transient antithrombin deficiency","volume":"116","author":"Navarro-Fernandez","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0210","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood-2012-01-406207","article-title":"Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism","volume":"120","author":"Martinez-Martinez","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.07.008_bb0215","doi-asserted-by":"crossref","first-page":"13688","DOI":"10.1074\/jbc.M300062200","article-title":"Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis","volume":"278","author":"Raja","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2018.07.008_bb0220","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2119\/molmed.2012.00017","article-title":"The infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency","volume":"18","author":"Martinez-Martinez","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.thromres.2018.07.008_bb0225","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood.V94.10.3388.422k20_3388_3396","article-title":"Formation of the antithrombin heterodimer in vivo and the onset of thrombosis","volume":"94","author":"Zhou","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2018.07.008_bb0230","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/jth.13372","article-title":"Hypoglycosylation is a common finding in antithrombin deficiency in the absenceof a SERPINC1 gene defect","author":"de la Morena-Barrio","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2018.07.008_bb0235","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1749-6632.2010.05840.x","article-title":"Congenital disorders of glycosylation","volume":"1214","author":"Jaeken","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481830416X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938481830416X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:53:42Z","timestamp":1661561622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938481830416X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":47,"alternative-id":["S004938481830416X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2018.07.008","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genetics of antithrombin","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2018.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}